Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
| Autor: | Yu, Jie-Hai *, Xiao, Bin-Yi *, Li, Dan-Dan *, Jiang, Wu *, Ding, Ya, Wu, Xiao-Jun, Zhang, Rong-Xin, Lin, Jun-Zhong, Wang, Wei, Han, Kai, Kong, Ling-Heng, Zhang, Xin-Ke, Chen, Bi-Yun, Mei, Wei-Jian, Pan, Zhi-Zhong †, Tang, Jing-Hua †, Zhang, Xiao-Shi †, Ding, Pei-Rong †, * |
|---|---|
| Zdroj: | In The Lancet Oncology July 2024 25(7):843-852 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|